Skip to main content

Table 1 Characteristics of 201 patients with chronic kidney disease and 201 controls without chronic kidney disease

From: The association of angiogenic factors and chronic kidney disease

 

CKD Patients

(N = 201)

Non-CKD

(N = 201)

P-value

Age, years

55.9 ± 9.9

52.5 ± 10.0

< 0.001

Male, %

55.2

45.3

0.06

African-American, %

60.7

51.2

0.06

Current cigarette smoking, %

53.7

48.8

0.32

Alcohol consumption, %

27.9

59.2

< 0.001

Physical activity ≥twice/week, %

53.0

72.9

< 0.001

High school education, %

58.5

81.6

< 0.001

History of CVD, %

43.7

7.0

< 0.001

History of hypertension, %

88.1

23.9

< 0.001

History of diabetes, %

49.3

5.5

< 0.001

History of hypercholesterolemia, %

65.7

30.9

< 0.001

Use of antihypertensive agents, %

79.6

15.4

< 0.001

Use of hypoglycemic agents, %

34.3

3.0

< 0.001

Use of lipid lowering agents, %

21.9

8.9

< 0.001

Use of aspirin, %

34.8

8.5

< 0.001

BMI, kg/m2

32.2 ± 7.8

28.9 ± 6.4

< 0.001

Systolic BP, mm Hg

132.2 ± 21.0

122.0 ± 14.7

< 0.001

Diastolic BP, mm Hg

77.2 ± 13.5

77.6 ± 9.4

0.77

LDL-cholesterol, mg/dL

101.8 ± 47.3

118.2 ± 30.2

< 0.001

HDL-cholesterol, mg/dL

50.3 ± 15.6

57.7 ± 18.0

< 0.001

Fasting plasma glucose, mg/dL

119.9 ± 46.8

103.4 ± 35.4

< 0.001

C-reactive protein mg/L

5.3 ± 11.7

4.1 ± 8.4

0.26

eGFR, mL/min/1.73 m2

43.3 ± 19.3

96.7 ± 16.8

< 0.001

Urinary albumin, mg/24 h

74.5 (12.3, 417.4)

5.9 (4.1, 11.4)

< 0.001

  1. Categorical variables are presented as percentages while continuous variables are presented as mean and standard deviation or median and interquartile range
  2. LDL low-density lipoprotein, HDL high-density lipoprotein, eGFR estimated glomerular filtration rate, BMI body mass index, BP blood pressure, CVD cardiovascular disease